- VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation Council) and continued support from existing investors Asabys Partners and Aliath Bioventures.
- Funding will be used to advance clinical trials for BCI therapeutics and support the team expansion to accelerate development and commercialization.
More information here: